BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210203T100000
DTEND;TZID=Europe/London:20210203T110000
DTSTAMP:20260421T210726
CREATED:20200902T133927Z
LAST-MODIFIED:20200902T133927Z
UID:18497-1612346400-1612350000@staging.medilinkmidlands.com
SUMMARY:POSTPONED: WEBINAR: Research location: Where and Why! Selecting and contracting with appropriate clinical research sites in uncertain times
DESCRIPTION:Unfortunately\, due to unforeseen circumstances\, this webinar has been postponed. The webinar will now take place on Thursday 11th March\, to book your free place\, please click here. \n  \nJoin us for the next in the series of our Clinical Trial Special Interest Groups with Afortiori Development at this webinar where we will be discussing research location: where and why! \nWhen it comes to making decisions about your chosen research trial setting\, there is much to consider. Join us to learn how to make the right location choice for your product and understand how patient pathways\, healthcare setting\, institutional policies\, geography and costs can affect your trial success. \nDURATION: 1 hour \nThis free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n\nCharlotte Culver\, Clinical Project Leader\, Afortiori Development\nCharlotte has a strong project management background in clinical research Phases I-V while delivering both commercial and non-commercial research throughout her career to produce quality results.\nShe is experienced in both pharmaceutical and device trials across several disease areas throughout the lifecycle of the project\, in collaboration with key pharmaceutical and device companies in the industry.\nHer proven project management track record provides her with the tools to deliver excellence and detailed delivery in clinical\, regulatory\, and financial aspects of clinical research.\nThroughout her research career\, she has worked on projects internationally\, as either multicentered or single-centre as lead. \n\nJames Fry\, Head of Life Sciences and Partner at Mills & Reeve\nJames heads the firm’s fast growing\, multi-disciplinary life sciences practice and focuses exclusively on this sector. The practice supports clients in the pharma and biotech\, medical device\, diagnostic\, medtech and digital health sub-sectors. James’ own practice focuses on intellectual property\, commercial contracting and regulatory work. \n 
URL:https://staging.medilinkmidlands.com/event/webinar-researchlocation/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/erdflogo2.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210223T100000
DTEND;TZID=Europe/London:20210223T110000
DTSTAMP:20260421T210726
CREATED:20210105T115540Z
LAST-MODIFIED:20210105T115540Z
UID:18492-1614074400-1614078000@staging.medilinkmidlands.com
SUMMARY:Life Sciences Marketing Special Interest Group (SIG) :Delivering engaging social media in 2021-how to succeed in B2B Life Sciences
DESCRIPTION:Join us online for our very first Life Sciences Marketing Special Interest Group (SIG) event\, focusing on the hot topic of B2B social media. Social media marketing is becoming much more prominent for B2B marketers and if used effectively it can become a powerful marketing channel for engagement and lead generation. \nLearn B2B social media insights from a leading expert – Mark Saxby\, Consultant and Director of Status Social; one of the UK’s first specialist social media agencies. Discover real life examples of how B2B businesses are using social media for success and gain hot tips to help you improve social media engagement and communication. \nThe event will be hosted by Robin Bodicoat\, Marketing Director\, Quotient Sciences\, who will also share his own insights and provide industry examples. \nYou can also take part in a live Q&A session. \nDURATION: 1 hour \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n \nRobin Bodicoat\, Marketing Director at Quotient Sciences \nRobin is the CIM qualified\, Marketing Director at Quotient Sciences\, a leading drug development services organization. He is also an active Board Member of the BMC (Business Marketing Club)\, which is the independent voice of the B2B marketing industry. He has 15+ years’ experience in Life Sciences\, Pharma and Healthcare\, with knowledge in marketing campaign planning and strategy\, and brand development. In 2017 he managed the global re-brand of Quotient Sciences. \n  \n  \n  \n \nMark Saxby\, Consultant & Director of Status Social \nMark Saxby is the director of Status Social\, a thriving social media consultancy based in Derby. He is a recognised social media expert and when not helping his clients to generate revenue through social\, Mark is an in-demand speaker and has presented alongside Google and Mars. \n  \n  \n  \n  \n 
URL:https://staging.medilinkmidlands.com/event/life-sciences-marketing-special-interest-group-sig-delivering-engaging-social-media-in-2021-how-to-succeed-in-b2b-life-sciences/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/png:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Mark-Saxby-headshot.png
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
END:VCALENDAR